Mymetics Corp.

Profile:

OVERVIEW: This biotechnology research and development company is developing an HIV vaccine as well as malaria, influenza and Respiratory Syncytial Virus (RSV) vaccines.

ADDRESS:
14, Rue de la Colombiere
Nyon

Phone: 011-41-22-363-13-10
Fax: 011-41-22-363-13-11
Web Site: http://www.mymetics.com

PRIMARY STOCK EXCHANGE: OTC Bulletin Board
TICKER SYMBOL: MYMX

AUDITORS: PETERSON SULLIVAN, P.P.C.
TRANSFER AGENT: Continental Stock Transfer & Trust Co., New York, NY

EMPLOYEES: 8
SHAREHOLDERS: 600

FOUNDED: 1994
DOMICILE: Delaware